Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
Global Next Generation Sequencing (NGS) Market: By Component: NGS Platforms, NGS services; By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Others; By Application; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Next Generation Sequencing (NGS) Market Outlook
The global next generation sequencing (NGS) market is projected to expand from USD 8 billion in 2020 to USD 24 billion by 2026 at a CAGR of 21% over the forecast period of 2021-2026.
-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Continuous technological innovation in sequencing technology has resulted in the development of reliable, powerful, low footprint, portable, and easy-to-use NGS platforms, which is aiding the growth of the global next generation sequencing (NGS) industry. Significant research and development have allowed systems to produce faster and more exact output and have raised product applications.
Properties and Applications
Next-generation sequencing is a new method of high-speed and low-cost genome sequencing. It is also known as the sequencing of the second generation or sequencing of large parallels. The global next generation sequencing (NGS) market can be divided based on segments like component, technology, and application.
-market-by-component.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be broadly categorised based on its component into:
- NGS Platforms
- NGS Services
The industry can be divided based on its technology as:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Other
The industry can be divided on the basis of its application as:
- Diagnostics
- Drug Discovery
- Agricultural and Animal Research
- Others
The EMR report looks into the regional next generation sequencing markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The advancements in systems for next-generation sequencing is driving the market growth. Technological advancements provide players with an immediate competitive edge, thus, ensuring consistent focus on product development and research. Developing advanced platforms provide players with a competitive edge, which aids the industry growth. Main players, as well as new players, are focusing on the continuous development to provide innovative sequencing technologies at a competitive price for various applications, which is expected to drive the industry over the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global next generation sequencing market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Illumina, Inc. (NASDAQ: ILMN )
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- PierianDx
- Genomatix GmbH
- Eurofins GATC Biotech GmbH
- Oxford Nanopore Technologies
- Macrogen, Inc.
- Thermo Fisher Scientific, Inc.
- DNASTAR, Inc.
- Biomatters Ltd.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Questions Answered in the Market Report
- How has the global next generation sequencing market performed in the previous years (2016-2020)?
- What is the forecast assessment of the market for 2021-2026?
- What are the major drivers for the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major constraints for the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major demand indicators of the global market?
- What is the degree of competition in the global market?
- What are the major events and developments taking place within the industry globally?
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Cost Structure
4.5 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Next Generation Sequencing (NGS) Market Analysis
6.1 Global Next Generation Sequencing (NGS) Historical Market (2016-2020) & Forecast (2021-2026)
6.2 Global Next Generation Sequencing (NGS) Market Breakup by Component
6.2.1 NGS Platforms
6.2.2 NGS Services
6.3 Global Next Generation Sequencing (NGS) Market Breakup by Component: Historical Market (2016-2020) & Forecast (2021-2026)
6.3.1 NGS Platforms
6.3.2 NGS Services
6.4 Global Next Generation Sequencing (NGS) Market Breakup by Technology
6.4.1 Sequencing by Synthesis
6.4.2 Ion Semiconductor Sequencing
6.4.3 Single-Molecule Real-Time Sequencing
6.4.4 Nanopore Sequencing
6.4.5 Other
6.5 Global Next Generation Sequencing (NGS) Market Breakup by Technology: Historical Market (2016-2020) & Forecast (2021-2026)
6.5.1 Sequencing by Synthesis
6.5.2 Ion Semiconductor Sequencing
6.5.3 Single-Molecule Real-Time Sequencing
6.5.4 Nanopore Sequencing
6.5.5 Other
6.6 Global Next Generation Sequencing (NGS) Market Breakup by Application
6.6.1 Diagnostics
6.6.2 Drug Discovery
6.6.3 Agricultural & Animal Research
6.6.4 Others
6.7 Global Next Generation Sequencing (NGS) Market Breakup by Application: Historical Market (2016-2020) & Forecast (2021-2026)
6.7.1 Diagnostics
6.7.2 Drug Discovery
6.7.3 Agricultural & Animal Research
6.7.4 Others
6.8 Global Next Generation Sequencing (NGS) Market Breakup by Region
6.8.1 North America
6.8.1.1 United States of America
6.8.1.2 Canada
6.8.2 Europe
6.8.2.1 Germany
6.8.2.2 United Kingdom
6.8.2.3 France
6.8.2.4 Italy
6.8.2.5 Others
6.8.3 Asia Pacific
6.8.3.1 China
6.8.3.2 Japan
6.8.3.3 India
6.8.3.4 ASEAN
6.8.3.5 Others
6.8.4 Latin America
6.8.4.1 Brazil
6.8.4.2 Argentina
6.8.4.3 Mexico
6.8.4.4 Others
6.8.5 Middle East & Africa
6.8.5.1 Saudi Arabia
6.8.5.2 United Arab Emirates
6.8.5.3 Nigeria
6.8.5.4 South Africa
6.8.5.5 Others
6.9 Global Next Generation Sequencing (NGS) Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
6.9.1 North America
6.9.1.1 United States of America
6.9.1.2 Canada
6.9.2 Europe
6.9.2.1 Germany
6.9.2.2 United Kingdom
6.9.2.3 France
6.9.2.4 Italy
6.9.2.5 Others
6.9.3 Asia Pacific
6.9.3.1 China
6.9.3.2 Japan
6.9.3.3 India
6.9.3.4 ASEAN
6.9.3.5 Others
6.9.4 Latin America
6.9.4.1 Brazil
6.9.4.2 Argentina
6.9.4.3 Mexico
6.9.4.4 Others
6.9.5 Middle East & Africa
6.9.5.1 Saudi Arabia
6.9.5.2 United Arab Emirates
6.9.5.3 Nigeria
6.9.5.4 South Africa
6.9.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 Competitive Landscape & Supplier Analysis
9.1 Illumina, Inc. (ILMN (NASDAQ))
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 F. Hoffmann-La Roche Ltd. (ROG (SWX))
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Agilent Technologies, Inc. (A (NYSE))
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 PierianDx
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Genomatix GmbH
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 Eurofins GATC Biotech GmbH
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Oxford Nanopore Technologies
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 Macrogen, Inc. (038290 (KOSDAQ))
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Thermo Fisher Scientific, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.10 DNASTAR, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.11 Biomatters Ltd.
9.11.1 Company Overview
9.11.2 Financial Analysis
9.12 Others
10 Industry Events and Development
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 1999
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2499-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$4199$3499-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4499-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar ReportsThe global cancer screening market is driven by the surging cancer rates around the globe. Aided by the growing technological advancements, the market is expected to witness a further growth in the fo...
The global testosterone test kits market is being driven by the rising healthcare infrastructure and growing endocrine testing market. Aided by the growing R&D activities, the endocrine testing market...
The global glycated haemoglobin testing market witnessed a healthy growth in the historical period of 2016-2020 aided by rising prevalence of diabetes. The market is expected to grow at a CAGR of 9% d...
The global lipase testing market is being driven by the growing patient pool and lipase market. Aided by the rising research activities, the lipase market is expected to witness a healthy growth in th...
The global cancer/tumour profiling market attained a value of USD around 7.8 billion in 2020. The cancer/tumour profiling market is further expected to grow in the forecast period of 2021-2026 at a CA...
NEWSLETTER